Meeting / Activity Detail
8:00 a.m. – 3:00 p.m.
Patient Viewing – Emory Dermatology Clinic
Lectures -
Keynote speaker: Sancy A. Leachman, MD, PhD
Agenda
7:30 - 8:00 am Patient Arrival, Emory Dermatology Clinic
9:20 am - 3:00
pm Scientific Sessions,
9:00 - 9:20 am Breakfast
9:20 - 10:15 am Sancy A. Leachman, MD, PhD
Update on Melanoma Genetics
Upon completion of this lecture the participant will:
1. Be familiar with the major molecular pathways involved in melanoma
2. Know which melanoma patients are candidates for genetic counseling and testing
3. Understand how to incorporate genetic testing into their clinical practice
10:15 - 11:10 am Sancy A. Leachman, MD, PhD
Cutaneous Cancer Syndromes
Upon completion of this lecture the participant will:
1. Recognize the major features of hereditary syndromes that have skin cancer manifestations (e.g. FAMMM, Basal Cell Nevus Syndrome)
2. Recognize the cutaneous signs of hereditary cancer syndromes (e.g. Cowden’s syndrome, Muir Torre syndrome)
3. Appreciate how to identify and refer patients with these syndromes for appropriate follow-up
11:10 - 11:30 am Break
11:30 - 12:25pm Sancy A. Leachman, MD, PhD
First-in-skin siRNA Therapeutic for Pachyonychia Congenita
Upon completion of this lecture the participant will:
1. Understand the mechanism of action of siRNA-based therapeutics
2. Know how to appropriately identify patients with pachyonychia congentia
3. Know how to refer patients with pachyonychia congenita for genetic testing and registry enrollment
12:25 - 12:45 pm Break and pick up boxed lunch
12:45 - 2:45 pm Light Working Lunch
Pathology Presentations and Discussion
2:45 - 3:00 pm Wrap up
RSVP for this Event Fill out the Patient Viewing Protocol Download - Case Details Form Download - Patient Information Form
Sancy Leachman, MD, PhD, is director of the Melanoma and Cutaneous Oncology Program, an associate professor in the Department of Dermatology at the University of Utah School of Medicine, and member of the Imaging, Diagnostics, and Therapeutics Program and the Cancer Control and Population Sciences Program. She is a dermatologist using basic science research and state-of-the-art technology to combat skin cancer.